ESC 365 - Real-world evidence complements randomised controlled trial data to inform daily clinical practice.

Open Access

Real-world evidence complements randomised controlled trial data to inform daily clinical practice.

Session: Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation

Topic: Atrial Fibrillation (AF)

Speaker: Doctor S. Deitelzweig (New Orleans, US)

Sponsored by BMS/Pfizer Alliance

Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Steven Deitelzweig

Ochsner Medical Center, New Orleans (United States of America)

7 presentations

0 follower

3 more presentations in this session

What can robust real-world evidence bring to the table?

Speaker: Professor G. Lip (Liverpool, GB)

Stroke prevention in sub-populations of patients with non-valvular atrial fibrillation.

Speaker: Professor G. Lip (Liverpool, GB)

Audience participation.

Speaker: Professor G. Lip (Liverpool, GB)

Access the full session

Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation

Speakers: Doctor S. Deitelzweig, Professor G. Lip, Professor G. Lip, Professor G. Lip

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by